French Guiana Tech World
SEE OTHER BRANDS

Your science and technology news reporter from French Guiana

French Guiana Tech World: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Tech World.

Press releases published on September 7, 2025

Personal Loan Credit Insurance Market 2025-2029: Unveiling Growth Developments with the Latest Updates

Personal Loan Credit Insurance Market 2025-2029: Unveiling Growth Developments with the Latest Updates

The Business Research Company’s Personal Loan Credit Insurance Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, September 8, 2025 /⁨EINPresswire.com⁩/ -- What Is The Expected Cagr For The …

DataGlobal Hub’s GDAI 2025 Showcases the World’s Brightest Minds in Data and AI

DataGlobal Hub’s GDAI 2025 Showcases the World’s Brightest Minds in Data and AI

PHOENIX, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Global Data …

Dianthus Therapeutics to Host Conference Call and Webcast to Discuss Results from Phase 2 MaGic Trial of Claseprubart (DNTH103) in Generalized Myasthenia Gravis

Dianthus Therapeutics to Host Conference Call and Webcast to Discuss Results from Phase 2 MaGic Trial of Claseprubart (DNTH103) in Generalized Myasthenia Gravis

NEW YORK and WALTHAM, Mass., Sept. 07, 2025 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune …

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

Junshi Biosciences Announces the Phase 3 Study of JS005 (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis Met Primary Endpoints

SHANGHAI, Sept. 07, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel …

Un estudio sobre la genética del cáncer de pulmón lanza una plataforma de datos de código abierto para la comunidad investigadora

Un estudio sobre la genética del cáncer de pulmón lanza una plataforma de datos de código abierto para la comunidad investigadora

SAN FRANCISCO, Sept. 07, 2025 (GLOBE NEWSWIRE) -- El Instituto de Investigación 23andMe, Troper Wojcicki Philanthropies (TWP) y Lifebit han anunciado hoy el lanzamiento oficial de una plataforma de datos de código abierto para el Estudio genético sobre el …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions